Page 101 - ESHRE2019
P. 101
Key questions
Human immunodeficiency virus (HIV)
Hepatitis B (HBV) Hepatitis C virus (HCV) Zika virus
Human papilloma Virus
(HPV)
Human T‐cell Lymphotropic
viruses I/II (HTLV‐I, HTLV‐II)
Patients (male/female) presenting with infertility and viral infection/disease
Male VD + Female VD ‐
Male VD ‐ Female VD +
Male VD + Female VD +
Prevalence viral infection/disease
Screening
Reducing viral load (M/F)
Natural conception
Vaccination Pre‐exposure prophylaxis Anti‐(retro)viral therapy ??
Anti‐(retro)viral drugs ‐ vaccination Caesarean section ‐ bottle‐feeding
MAR
Vaccination
Pre‐exposure prophylaxis Anti‐(retro)viral therapy
Sperm washing
Oocyte rinsing
PCR testing
Medical staff safety precautions
Vaccination Anti‐(retro)viral therapy
Clear of virus? Viral load (levels)
Key questions - Background
1. Prevalence of viral infections?
2. How should testing prior to MAR be performed?
96
PRECONGRESS COURSE 12 I VIENNA, AUSTRIA – 23 JUNE 2019 99
Post‐ Conception Pre‐ conception (MAR) conception
